Intended for healthcare professionals


Major US consumer group asks FDA to ban drug for diabetes

BMJ 2008; 337 doi: (Published 05 November 2008) Cite this as: BMJ 2008;337:a2401
  1. Janice Hopkins Tanne
  1. 1New York

    Public Citizen, a US national consumer advocacy group, has petitioned the US Food and Drug Administration to ban the drug rosiglitazone (sold as Avandia), which is prescribed for type 2 diabetes.

    The group said that liver failure, often fatal, was a newly documented risk with the drug, which is made by GlaxoSmithKline. Previously the drug had been linked to an increased risk of heart attacks, heart failure, bone fractures, and eye problems, Public Citizen said.

    The drug now carries a “black box” warning from the …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription